NLS Finland

Career choice - June 13, 2022

Chief Medical Officer

As Chief Medical Officer (CMO) at Faron Pharmaceuticals Marie-Louise Fjällskog can combine her passion for science and helping people with her fascination for finding solutions to detective stories.

Collaboration - May 16, 2022

BC Platforms announces partnerships with three Finnish biobanks

BC Platforms has secured a multi-year contract to work with three Finnish Hospital District owned Biobanks (Clinical Biobanks) on improving access to, and automated management of, phenotypic, genomic, and clinical data. The project underpins Finland’s ambition to be a leading country for Real-World Data (RWD) studies, supporting the global development of novel treatments and enhancing […]

Collaboration - March 16, 2022

AstraZeneca and Business Tampere offer a mentoring program

AstraZeneca offers ”one-off” business mentoring sessions for selected startups that are aspiring business and collaboration with the pharma industry. The application period for the mentoring program is open now and applicants all around Finland are welcome, reports Business Tampere. A unique opportunity “This is a unique opportunity and Tampere is the only location in Finland […]

Careers article - March 14, 2022

Finland’s first professorship for individualized cancer treatment

The purpose of the new professorship is to promote cancer research that moves patient care towards a more individualized direction. On the World Cancer Day of 4 February it was announced that Finland’s first professorship for individualized cancer treatment will be established in connection with the University of Helsinki and Helsinki University Hospital. ”A professorship […]

Uncategorized - March 1, 2022

Nordic scientists tailor leukemia therapy using functional precision medicine approach

A functional precision medicine study conducted in Finland demonstrates that treatment selection based on results from drug sensitivity testing of patients’ cells can be clinically useful in patients with aggressive hematological cancers. Clinicians, researchers and technology experts from the Institute for Molecular Medicine Finland FIMM at the University of Helsinki and Helsinki University Hospital Comprehensive […]

Financing - November 15, 2021

Valo Therapeutics raises 11 million EUR

Valo Therapeutics has successfully raised 11 million EUR in an oversubscribed Pre-IPO funding round. The Pre-IPO fund included participation from existing investors, Freeman Road, and new investors, including ASX-listed MMJ Group Holdings. The total raised to date is now over Euro 22 million (around USD 25.5 million). “This successful financing is yet another significant milestone […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.